Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

eurimpharm arzneimittel gmbh (8050167) - glucagonhydrochlorid (1:x) ((mit angaben zum chlorwasserstoff-gehalt)) - pulver und lösungsmittel zur herstellung einer injektionslösung - 1 mg - teil 1 - pulver; glucagonhydrochlorid (1:x) ((mit angaben zum chlorwasserstoff-gehalt)) (06852) 1 milligramm

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eurogenerics afgekort "e.g." - propranolol hydrochloride - tablette - 40 mg - propranolol hydrochloride 40 mg - propranolol

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eurogenerics afgekort "e.g." - propranolol hydrochloride - hartkapsel, retardiert - 160 mg - propranolol hydrochloride 160 mg - propranolol

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cheplapharm arzneimittel - acebutolol hydrochloride - filmtablette - 400 mg - acebutolol hydrochloride 443.4 mg - acebutolol

Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cheplapharm arzneimittel - acebutolol hydrochloride - filmtablette - 200 mg - acebutolol hydrochloride 221.71 mg - acebutolol

Europäische Union - Deutsch - EMA (European Medicines Agency)

accord healthcare s.l.u. - sitagliptin hydrochloride - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - for adult patients with type 2 diabetes mellitus, sitagliptin accord is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (ppary) agonist (i. a thiazolidinedione) when use of a ppary agonist is appropriate and when diet and exercise plus the ppary agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a ppary agonist and metformin when use of a ppary agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin accord is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

Europäische Union - Deutsch - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Europäische Union - Deutsch - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metformin-hydrochlorid - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

1 a pharma gmbh (8013083) - vildagliptin; metforminhydrochlorid - filmtablette - teil 1 - filmtablette; vildagliptin (30957) 50 milligramm; metforminhydrochlorid (06150) 1000 milligramm

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

1 a pharma gmbh (8013083) - vildagliptin; metforminhydrochlorid - filmtablette - teil 1 - filmtablette; vildagliptin (30957) 50 milligramm; metforminhydrochlorid (06150) 850 milligramm